Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

Clinical trial NCT03549273 · UNKNOWN

Trial details

NCT number: NCT03549273
Sponsor: Catalysis SL
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma Neoplasia; Intraepithelial, Cervix Glandular Neoplasms Epithelial Neoplasm Neoplasms

Start date: 2019-03-11
Primary completion: 2024-12-15
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.